GlassScriptPhysician profile
Jason Thomas Salsamendi
NPI 1497999148
$13,287.83
in general payments reported to CMS, 2019-2025
20 companies · $4,051 in 2025
The $4,051 reported for 2025 was more than what 94% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $37.11 · 2021: $129 · 2022: $4,868 · 2023: $153 · 2024: $3,697 · 2025: $4,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,750 · Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,750.00 |
| Food and Beverage | $1,151.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $7,278.81 | 2022-2025 | Artis Icono Floor, Artis Icono Biplane, Magnetom Vida |
| Trisalus Life Sciences, INC. | $2,865.31 | 2022-2025 | Trinav Infusion System |
| Penumbra, INC. | $1,102.13 | 2022 | |
| Terumo Medical Corporation | $606.59 | 2019-2022 | |
| Boston Scientific Corporation | $320.73 | 2020-2025 | Embold Fibered |
| Inari Medical, INC. | $221.85 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $194.33 | 2019-2025 | Venacure 1470 Pro |
| Bard Peripheral Vascular, INC. | $146.93 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $124.58 | 2022 | |
| Medical Device Business Services, INC. | $121.30 | 2019 | |
| Medtronic, INC. | $89.53 | 2021-2022 | |
| Medtronic USA, INC. | $46.19 | 2019 | |
| Genentech USA, INC. | $43.66 | 2022 | |
| Cascination Ag | $32.47 | 2024 | Cas-One Ir |
| Cardiva Medical, INC. | $23.62 | 2024 | Cardiva Vascade 6/7f Vcs |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $23.07 | 2022 | |
| Telix Pharmaceuticals | $19.41 | 2022 | |
| Biocompatibles, INC. | $14.11 | 2019 | |
| Becton, Dickinson and Company | $13.21 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Salsamendi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.